Iron Dysregulation: Looking Deeper Into Iron Metabolism

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Iron dysregulation occurs when the body’s ability to absorb, transport, or utilise iron is impaired—often despite “normal” ferritin levels. Chronic inflammation can disrupt iron metabolism through the hormone hepcidin, leading to functional iron deficiency, where iron is present in the body but unavailable to cells. Looking beyond ferritin to markers such as transferrin, transferrin saturation, and inflammation markers provides a more accurate assessment of iron status.

Understanding Iron Dysregulation

Iron is essential for oxygen transport, mitochondrial energy production, immune function, and cognitive performance. When iron metabolism becomes dysregulated, symptoms such as fatigue, poor concentration, reduced exercise tolerance, and increased susceptibility to infections may develop (1). These patterns commonly overlap with individuals seeking support for chronic fatigue.

Ferritin is commonly used to assess iron stores, but it does not always reflect how well iron is being utilised. Because ferritin is an acute-phase reactant, levels may appear normal or elevated during inflammation, masking underlying functional iron deficiency (2,3).

The Role of Chronic Inflammation

Chronic inflammation—associated with autoimmune disease, persistent infection, metabolic dysfunction, or obesity—has a profound impact on iron regulation (4).

A key regulator in this process is hepcidin, a liver-derived hormone that controls iron absorption from the intestine and the release of iron from storage sites such as macrophages and hepatocytes (5).

Inflammatory cytokines stimulate hepcidin production, reducing intestinal iron absorption and trapping iron within cells. This leads to functional iron deficiency, where circulating iron is insufficient for erythropoiesis and cellular metabolism despite adequate or elevated iron stores (6,7).

Markers That Provide Deeper Insight

Accurately identifying iron dysregulation requires a broader panel than ferritin alone. Important markers include:

Transferrin

Transferrin is the primary iron transport protein in blood. Low transferrin levels may reflect inflammation or poor protein status, while elevated transferrin often indicates iron deficiency as the body attempts to increase iron transport capacity (8).

Transferrin Saturation

Transferrin saturation reflects the proportion of transferrin bound to iron. Values below ~20% suggest limited iron availability, whereas levels above ~45% may indicate iron overload or impaired iron regulation (9).

Inflammation Markers (CRP and ESR)

C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) help determine whether inflammation is contributing to impaired iron absorption or utilisation. Elevated markers can explain iron-restricted erythropoiesis even when ferritin is within range (10).

Why Deeper Testing Matters

Evaluating iron markers together allows practitioners to distinguish between absolute iron deficiency, functional iron deficiency, and iron sequestration due to inflammation. This reduces the risk of inappropriate iron supplementation, which may be ineffective or harmful when iron is trapped at the cellular level (11,12).

Because iron absorption occurs primarily in the small intestine, disturbances in digestion and microbial balance may also play a role. Exploring the gut microbiome can be an important part of understanding iron dysregulation.

When to Consider Further Investigation

A comprehensive iron assessment may be warranted if you experience:

  • Persistent fatigue despite normal ferritin
  • Brain fog or reduced exercise tolerance
  • Frequent infections or impaired recovery
  • Known inflammatory, autoimmune, or metabolic conditions

Frequently Asked Questions

Can ferritin be normal but iron still be functionally low?

Yes. Ferritin reflects iron storage but does not reliably indicate iron availability to tissues, particularly in the presence of inflammation (2).

Is functional iron deficiency the same as iron deficiency anaemia?

No. Functional iron deficiency refers to impaired iron utilisation and may occur before anaemia develops or without significant changes in haemoglobin (6).

Is iron supplementation always appropriate?

Not necessarily. When iron dysregulation is driven by inflammation, addressing underlying causes may be more effective than iron supplementation alone (11).

Key Insights

  • Iron metabolism is tightly regulated and highly sensitive to inflammation
  • Hepcidin plays a central role in functional iron deficiency
  • Ferritin alone does not provide a complete picture of iron status
  • Interpreting multiple iron and inflammation markers improves diagnostic accuracy

Takeaway

Iron health is rarely as simple as a single blood test. When symptoms persist despite “normal” ferritin, a deeper evaluation of iron metabolism can reveal clinically meaningful patterns that standard testing often misses.

Next Steps

Addressing iron dysregulation often involves identifying and reducing inflammatory drivers, supporting gut and metabolic health, and interpreting iron markers in clinical context. In some individuals, iron-related symptoms overlap with endocrine patterns such as thyroid dysfunction, reinforcing the importance of whole-system assessment (14).

References

  1. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr. 2001 Feb;131(2S-2):568S-579S. https://doi.org/10.1093/jn/131.2.568S
  2. Wang W et al. Ferritin as an inflammatory marker: clinical utility and limitations. Clin Chim Acta. 2010 Nov;411(21-22):1615-9. https://doi.org/10.1016/j.cca.2010.07.019
  3. Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014 Apr;6(4):748-73. https://doi.org/10.1039/c3mt00347g
  4. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005 Mar 10;352(10):1011-23. https://doi.org/10.1056/NEJMra041809
  5. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011 Apr 28;117(17):4425-33. https://doi.org/10.1182/blood-2010-12-322156
  6. Nemeth E et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004 Dec 17;306(5704):2090-3. https://doi.org/10.1126/science.1104742
  7. Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Blood. 2015 Oct 1;126(14):1668-75. https://doi.org/10.1182/blood-2015-06-649426
  8. Cook JD et al. Serum transferrin receptor is a reliable index of iron status in inflammatory states. Blood. 1993 Dec 15;82(12):3723-9. https://pubmed.ncbi.nlm.nih.gov/8251143/
  9. Oustamanolakis P, Koutroubakis IE. Iron deficiency in inflammatory bowel disease: diagnosis and treatment. World J Gastroenterol. 2011 May 14;17(18):2313-9. https://doi.org/10.3748/wjg.v17.i18.2313
  10. Means RT. Iron deficiency and inflammation. Hematology Am Soc Hematol Educ Program. 2013;2013:276-80. https://doi.org/10.1182/asheducation-2013.1.276
  11. Pasricha SR et al. Risks and benefits of iron supplementation in iron-deficient but non-anaemic individuals. Lancet Haematol. 2021 Apr;8(4):e306-e316. https://doi.org/10.1016/S2352-3026(21)00007-2
  12. Litton E et al. Safety of intravenous iron in patients with inflammation: a systematic review. BMJ Open. 2013 Apr 30;3(4):e002746. https://doi.org/10.1136/bmjopen-2013-002746
  13. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet. 2007 Aug 11;370(9586):511-20. https://doi.org/10.1016/S0140-6736(07)61235-5
  14. Duntas LH. Thyroid disease and anemia: a bidirectional relationship. Thyroid. 2015 Dec;25(12):1305-12. https://doi.org/10.1089/thy.2015.0385
  15. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015 May 7;372(19):1832-43. https://doi.org/10.1056/NEJMra1401038